Robert D. Budens

Array ( [id] => 4240755 [patent_doc_number] => 06136321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Method of inactivating lipid-enveloped viruses' [patent_app_type] => 1 [patent_app_number] => 9/021146 [patent_app_country] => US [patent_app_date] => 1998-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5928 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136321.pdf [firstpage_image] =>[orig_patent_app_number] => 021146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4291951 [patent_doc_number] => 06197531 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Method for determining the immunocompetence of a mammal and therapies related thereto' [patent_app_type] => 1 [patent_app_number] => 9/009958 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7713 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197531.pdf [firstpage_image] =>[orig_patent_app_number] => 009958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154744 [patent_doc_number] => 06156541 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-05 [patent_title] => 'Compositions and methods for catalyzing hydrolysis of HIV gp120' [patent_app_type] => 1 [patent_app_number] => 9/000023 [patent_app_country] => US [patent_app_date] => 1998-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5916 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/156/06156541.pdf [firstpage_image] =>[orig_patent_app_number] => 000023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406861 [patent_doc_number] => 06265160 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Method of identifying inhibitors of the Jak-Stat signal transduction pathway' [patent_app_type] => 1 [patent_app_number] => 9/003903 [patent_app_country] => US [patent_app_date] => 1998-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 9703 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265160.pdf [firstpage_image] =>[orig_patent_app_number] => 003903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939400 [patent_doc_number] => 05989819 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-23 [patent_title] => 'Method for quantitatively determining an antibody having the ability to inhibit the activity of a reverse transcriptase' [patent_app_type] => 1 [patent_app_number] => 8/952282 [patent_app_country] => US [patent_app_date] => 1997-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21124 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/989/05989819.pdf [firstpage_image] =>[orig_patent_app_number] => 952282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3973225 [patent_doc_number] => 05948368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-07 [patent_title] => 'Method of determining calibration curve and analysis method and apparatus using the same' [patent_app_type] => 1 [patent_app_number] => 8/947658 [patent_app_country] => US [patent_app_date] => 1997-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 9649 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 442 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/948/05948368.pdf [firstpage_image] =>[orig_patent_app_number] => 947658 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4009997 [patent_doc_number] => 05962446 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Therapetutic treatment for human T cell lymphotrophic virus type 1 infection' [patent_app_type] => 1 [patent_app_number] => 8/917517 [patent_app_country] => US [patent_app_date] => 1997-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4912 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962446.pdf [firstpage_image] =>[orig_patent_app_number] => 917517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105923 [patent_doc_number] => 06057102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'HIV coreceptor mutants' [patent_app_type] => 1 [patent_app_number] => 8/907468 [patent_app_country] => US [patent_app_date] => 1997-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 29970 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057102.pdf [firstpage_image] =>[orig_patent_app_number] => 907468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4196933 [patent_doc_number] => 06013515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'Cofactors for HIV-1 protein Tat and methods of use therefor' [patent_app_type] => 1 [patent_app_number] => 8/908332 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 19409 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013515.pdf [firstpage_image] =>[orig_patent_app_number] => 908332 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4109408 [patent_doc_number] => 06045795 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Methods and compositions for ameliorating the symptoms of sepsis' [patent_app_type] => 1 [patent_app_number] => 8/906400 [patent_app_country] => US [patent_app_date] => 1997-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12070 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/045/06045795.pdf [firstpage_image] =>[orig_patent_app_number] => 906400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876656 [patent_doc_number] => 05804440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Human neutralizing monoclonal antibodies to human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/899575 [patent_app_country] => US [patent_app_date] => 1997-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 60 [patent_no_of_words] => 61567 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804440.pdf [firstpage_image] =>[orig_patent_app_number] => 899575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105812 [patent_doc_number] => 06057095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Screening procedure for inhibitors of HIV Rev function' [patent_app_type] => 1 [patent_app_number] => 8/893793 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9786 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057095.pdf [firstpage_image] =>[orig_patent_app_number] => 893793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1549672 [patent_doc_number] => 06399294 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens' [patent_app_type] => B1 [patent_app_number] => 08/817441 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 44 [patent_no_of_words] => 24974 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399294.pdf [firstpage_image] =>[orig_patent_app_number] => 08817441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3990943 [patent_doc_number] => 05985543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Compositions and methods for detection of antibody binding to cells' [patent_app_type] => 1 [patent_app_number] => 8/884046 [patent_app_country] => US [patent_app_date] => 1997-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 14780 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/985/05985543.pdf [firstpage_image] =>[orig_patent_app_number] => 884046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034503 [patent_doc_number] => 05994515 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-30 [patent_title] => 'Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/882435 [patent_app_country] => US [patent_app_date] => 1997-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 15191 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/994/05994515.pdf [firstpage_image] =>[orig_patent_app_number] => 882435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4151200 [patent_doc_number] => 06107019 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Method for preventing HIV-1 infection of CD4.sup.+ cells' [patent_app_type] => 1 [patent_app_number] => 8/876078 [patent_app_country] => US [patent_app_date] => 1997-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 12240 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107019.pdf [firstpage_image] =>[orig_patent_app_number] => 876078 [rel_patent_id] =>[rel_patent_doc_number] =>)